(Hypertension. 2000;36:952.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Clinical Pharmacology (S.C.M., F.G.G., R.P.K., J.M.R., P.J.C.), Centre for Cardiovascular Biology and Medicine, Kings College, London, UK, and the Department of Cardiology (K.P., J.R.C.), University of Wales College of Medicine, Cardiff, UK.
Correspondence to Dr P.J. Chowienczyk, Department of Clinical Pharmacology, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK. E-mail phil.chowienczyk{at}kcl.ac.uk
| Abstract |
|---|
|
|
|---|
Key Words: plethysmography hypertension, essential pulse nitroglycerin tonometry
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
3 measurements of office blood pressure
>140/90 mm Hg separated by at least 1 week. None of the
hypertensive subjects had clinical evidence of
cardiovascular disease other than hypertension. Twelve
were receiving antihypertensive therapy at the time of the study
(diuretics, 7 of 12; ß-adrenoreceptor
antagonists, 5 of 12;
-adrenoreceptor
antagonists, 1 of 12; ACE inhibitors, 3 of 12;
angiotensin II receptor antagonists, 2 of 12;
and calcium channel blockers, 4 of 12). Blood pressure at the time of
the study in the hypertensive subjects was 152±14/92±12 mm Hg.
The study was approved by St Thomas Hospital Research Ethics
Committee, and all subjects gave written informed consent.
Pressure and Volume Pulse Recording
Photoplethysmographic digital volume was determined by use of an
infrared lightemitting diode (940 nm) and phototransistor (Micro
Medical) applied to either side of the index finger of the right hand.
Applanation tonometry was used to record Prad
by use of a piezo-resistive cantilever transducer (Millar SPT 301,
Millar Instruments) applied over the radial artery of the left arm.
Pdig was measured noninvasively by use of a
servocontrolled pressure cuff device13 (Finapres 2300,
Ohmeda) applied to the middle finger of the right hand. Previous
studies have shown that changes in pressure recorded by the
tonometer14 15 and Finapres16 accurately
reflect changes in intra-arterial blood pressure. Signals
from all transducers were amplified, displayed in real time, digitized,
and recorded via a 12-bit analog-to-digital converter (sampling
frequency 100 Hz). Further digital signal processing was performed
offline. Brachial artery pressure (left arm) was measured by use of an
automated oscillometric method (Dinamap, Critikon). Because the purpose
of the present study was to compare the shape of the waveforms, all
waveforms were normalized to the same amplitude (nominally equal to
brachial artery pulse pressure).
Protocol
Subjects rested supine in a temperature-controlled laboratory
(26±1°C) for 30 minutes. Simultaneous pressure and
volume waveforms were recorded for 30 seconds at 5-minute intervals
for 15 minutes. In a subset of 20 of the normotensive subjects, NTG
(500 µg) was then administered sublingually, and further
simultaneous volume and pressure recordings were
obtained 3 minutes after NTG when the effects of NTG were
maximal.
Data Analysis
Pressure and volume waveforms in the time domain for each
individual were ensemble-averaged (with periodicity normalized to 1
second by scaling the time axis). ITF relating
Prad to the DVP waveform and relating the
Pdig waveform to the DVP waveform in the
frequency domain were determined from fast Fourier transforms (FFTs) of
waveforms for each individual:
ITF(Prad/DVP)=FFT(Prad)/FFT(DVP)
and
ITF(Pdig/DVP)=FFT(Pdig)/FFT(DVP).
The first 10 harmonics of each waveform were used for this analysis because higher harmonics do not contribute significantly.5 17 18 ITFs were determined at baseline and 3 minutes after NTG administration (when changes due to NTG were maximal) by use of a minimum of 6 consecutive stable cycles obtained from all 3 transducers. GTFs for resting waveforms and 3 minutes after NTG administration were derived by averaging ITFs at baseline and after NTG administration. The mean GTF for all subjects was used to predict pressure waveforms from the volume waveforms. The agreement between predicted and measured waveforms was quantified by the root mean square (RMS) difference between the 2 signals. In addition, we measured the height of the IP and compared changes in IP in the predicted and measured waveforms after NTG administration. The IP was defined as the point immediately preceding the second peak of the waveform (occurring in early diastole), at which the first derivative of the volume signal was maximum and was expressed as a percentage of the waveform amplitude.12
Statistical Analysis
Results are presented as mean±SD. ANOVA (for repeated
measures where appropriate) was used to compare differences in IP and
RMS errors between the groups and waveforms. A value of
P<0.05 was taken as significant.
| Results |
|---|
|
|
|---|
|
After the administration of NTG to a subset of the normotensive subjects, systolic blood pressure fell by 1.2±6.0 mm Hg (P=NS), and diastolic blood pressure fell by 5.2±3.8 mm Hg (P<0.001). NTG produced qualitatively similar changes in all 3 waveforms with a decrease in IP. Mean changes from baseline in IP after NTG administration were 22.9±4.9%, 11.3±4.7%, and 13.3±4.7% units (each P<0.001) for the DVP, Prad, and Pdig waveforms, respectively.
GTFs relating the volume waveforms to the pressure waveforms for normotensive subjects, hypertensive subjects, and normotensive subjects after NTG administration are shown in Figure 2. Average pressure waveforms obtained by applying the GTF (derived from all subject groups) to the volume waveforms, together with measured waveforms, are shown in Figure 3. Transformed volume waveforms were in close agreement with measured pressure waveforms in each artery. RMS errors between the pressure waveforms and between the transformed volume and pressure waveforms were similar and did not differ significantly between the various study groups (Table). RMS errors between transformed volume and pressure waveforms in treated hypertensive subjects did not differ significantly from those in untreated subjects. For all subjects, the mean RMS error for the difference between transformed volume and tonometer Prad signals was 4.4±2.0 mm Hg, and that for the difference between transformed volume and Finapres Pdig signals was 4.3±1.9 mm Hg. These errors did not differ significantly from the RMS error between the measured Prad and Pdig waveforms (4.4±1.4 mm Hg). There was a small but significant difference in the change in height of the IP after NTG administration in the Prad waveform predicted from the volume waveform and that obtained directly from the measured Prad waveform (15.4±4.1% versus 11.3±4.7%, P<0.05). The change in height of the IP after NTG administration in the Pdig waveforms predicted from the volume waveform was similar to that obtained from the measured Finapres waveform (13.4±3.9% versus 13.3±4.7%, P=NS).
|
|
|
| Discussion |
|---|
|
|
|---|
The major change in the peripheral pressure pulse after NTG administration is a lowering of the IP in the downslope of the waveform. Extensive theoretical and experimental work suggests that this results from reduced pressure wave reflection predominantly from the lower body.5 6 NTG also causes marked changes in the volume pulse. Indeed, in the present direct comparison, the change in the IP of the volume pulse after NTG administration was approximately twice that seen in the pressure pulses. Such changes in the volume pulse after NTG administration have been variously attributed to alterations in left ventricular preload or afterload,3 20 21 although no direct evidence has been presented to support these proposed mechanisms. The present study shows that the relationship between the pressure and volume pulse in the frequency domain remains constant, irrespective of the effects of NTG. Thus, although the effects of NTG on the pressure and volume waveforms will vary in a complex manner depending on the amplitude of the various harmonics of the waveforms, the change in one waveform is uniquely related to that in the other and can be predicted by using a single GTF. Therefore, the effects of NTG on the volume and pressure pulse are likely to be caused by the same mechanism. The relationship between digital volume and pressure in the digital artery is determined by the impedance characteristics of vessels in the finger distal to the digital arteries. The constancy of the relationship between volume and pressure in the presence of large changes in both caused by NTG suggests that the effects of NTG on peripheral impedance characteristics of the finger are minor compared with changes in arteries in the lower body that alter wave reflection. This is consistent with the observation that the effects of NTG on pulse-wave transmission along the upper limb are minor compared with the effects on wave reflection from the lower body.8
Takazawa et al4 have recently shown that the DVP may be used to demonstrate changes relating to drug effects and aging. Their analysis involved the ratio of measurements obtained from the second derivative with respect to time of the DVP waveform. Although providing quantitative indices of drug effects and the effects of aging, the physical meaning of such measurements is difficult to interpret. The present study supports our previous findings that the simple measurement of DVP IP provides an index of pressure-wave reflection.12 A number of investigators have shown that the central aortic pressure pulse can be derived from the peripheral pressure pulse.8 18 22 The present study suggests that such an analysis could equally be applied to the volume pulse. Although variance in transfer functions >6 Hz may limit the accuracy of such a secondary transformation, this may be offset by the similarity of the DVP to carotid artery pressure.5 Thus, central aortic pressure obtained from the DVP may be relatively independent of the exact form of a transfer function and, hence, allow semiquantitative effects of drugs on central pressure to be obtained without the need to use a transfer function. Measurement of the volume pulse offers a number of practical advantages over measurement of the pressure pulse. Photoplethysmography is inexpensive and, unlike tonometry, is operator independent. Furthermore, the technique is ideal for pharmacological studies in which continuous monitoring of drug effects is required. The only drawback with photoplethysmography relates to the damping of the signal as a result of peripheral vasoconstriction.3 In the present study, this was avoided by studying subjects in a warm laboratory. In conclusion, we have shown that the peripheral pressure pulse is related to the DVP by a transfer function that is not influenced by effects of hypertension or those of NTG. The effects of NTG on the volume pulse and pressure pulse are thus influenced by the same mechanism, likely to be a reduction in pulse-wave reflection. The volume pulse is likely to be useful in assessing the effects of drugs on pulse-wave reflection.
| Acknowledgments |
|---|
Received April 7, 2000; first decision April 20, 2000; accepted June 26, 2000.
| References |
|---|
|
|
|---|
2. Morikawa Y. Characteristic pulse wave caused by organic nitrates. Nature. 1967;213:841842.[Medline] [Order article via Infotrieve]
3. Lund L. Digital pulse plethysmography in studies of the haemodynamic response to nitrates: a survey of recording methods and principles of analysis. Acta Pharmacol Toxicol. 1986;59:7996.
4.
Takazawa K, Tanaka N, Fujita M, Matsuoka O, Saiki T,
Aikawa M, Tamura S, Ibukiyama C. Assessment of vasoactive agents and
vascular aging by the second derivative of photoplethysmograph
waveform. Hypertension. 1998;32:365370.
5. Nichols WW, ORourke MF. McDonalds Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. London, UK: Arnold; 1998.
6. ORourke MF, Kelly R, Avolio A. The Arterial Pulse. Malvern, Pa: Lea & Febiger; 1992.
7. ORourke MF, Gallagher DE. Pulse wave analysis. J Hypertens. 1996;14:S147S157.
8.
Karamanoglu M, ORourke MF, Avolio AP, Kelly RP. An
analysis of the relationship between central aortic and
peripheral upper limb pressure waves in man. Eur
Heart J. 1993;14:160167.
9. Murrell W. Nitro-glycerine as a remedy for angina pectoris. Lancet. 1879;80:801,113115,151152,225227.
10. Takazawa K. A clinical study of the second component of left ventricular systolic pressure. J Tokyo Med Coll. 1987;45:256270.
11. Yaginuma T, Avolio A, ORourke M, Nichols W, Morgan JJ, Roy P, Baron D, Branson J, Fenley M. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res. 1986;20:153160.[Medline] [Order article via Infotrieve]
12.
Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC,
Andersson TLG, Gosling RG, Ritter JM, Änggård EE.
Photoplethysmographic assessment of pulse wave reflection: blunted
endothelium-dependent response to
beta2 adrenergic vasodilation in type II
diabetes. J Am Coll Cardiol. 1999;34:20072014.
13. Boehmer RD. Continuous, real-time, noninvasive monitor of blood pressure: Peñaz methodology applied to the finger. J Clin Monit. 1987;3:282287.[Medline] [Order article via Infotrieve]
14.
Kelly RP, Hayward CS, Avolio AP, ORourke MF.
Noninvasive determination of age-related changes in the human
arterial pulse. Circulation. 1989;80:16521659.
15. Kelly R, Hayward C, Ganis J, Daley J, Avolio A, ORourke M. Non-invasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry. J Vasc Med Biol. 1989;1:142149.
16. Imholtz BPM, van Montfrans GA, Settels JJ, van der Hoven GM, Karemake JM, Wieling W. Continuous non-invasive monitoring: reliability of Finapres device during the Valsalva manoeuvre. Cardiovasc Res. 1988;22:390397.[Medline] [Order article via Infotrieve]
17. Safar ME. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens. 1989;7:769776.[Medline] [Order article via Infotrieve]
18.
Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL,
Kass DA. Estimation of central aortic pressure waveform by mathematical
transformation of radial tonometry pressure: validation of generalized
transfer function. Circulation. 1997;95:18271836.
19.
Imholtz BPM, Wieling W, van Montfrans GA, Wesseling KH.
Fifteen years experience with finger arterial blood
pressure monitoring: assessment of the technology. Cardiovasc
Res. 1998;38:605616.
20. Stengele E, Winkler F, Trenk D, Jähnchen E, Peterson J, Roskamm H. Digital pulse plethysmography as a non-invasive method for predicting drug-induced changes in left ventricular preload. Eur J Clin Pharmacol. 1996;50:279282.[Medline] [Order article via Infotrieve]
21. Imhof PR, Ott B, Frankhauser P, Chu LC, Hodler J. Difference in nitroglycerin dose-response in the venous and arterial beds. Eur J Clin Pharmacol. 1980;18:455460.[Medline] [Order article via Infotrieve]
22.
Karamanoglu M, Feneley MP. On-line synthesis of the
human ascending aortic pulse from the finger pulse.
Hypertension. 1997;30:14161424.
This article has been cited by other articles:
![]() |
E. M. Urbina, R. V. Williams, B. S. Alpert, R. T. Collins, S. R. Daniels, L. Hayman, M. Jacobson, L. Mahoney, M. Mietus-Snyder, A. Rocchini, et al. Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement From the American Heart Association Hypertension, November 1, 2009; 54(5): 919 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hashimoto and S. Ito Some mechanical aspects of arterial aging: physiological overview based on pulse wave analysis Therapeutic Advances in Cardiovascular Disease, October 1, 2009; 3(5): 367 - 378. [Abstract] [PDF] |
||||
![]() |
S. Munir, B. Jiang, A. Guilcher, S. Brett, S. Redwood, M. Marber, and P. Chowienczyk Exercise reduces arterial pressure augmentation through vasodilation of muscular arteries in humans Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1645 - H1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. DeLoach and R. R. Townsend Vascular Stiffness: Its Measurement and Significance for Epidemiologic and Outcome Studies Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 184 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Munir, A. Guilcher, T. Kamalesh, B. Clapp, S. Redwood, M. Marber, and P. Chowienczyk Peripheral Augmentation Index Defines the Relationship Between Central and Peripheral Pulse Pressure Hypertension, January 1, 2008; 51(1): 112 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Alnaeb, V. P. Crabtree, A. Boutin, D. P. Mikhailidis, A. M. Seifalian, and G. Hamilton Prospective Assessment of Lower-Extremity Peripheral Arterial Disease in Diabetic Patients Using a Novel Automated Optical Device Angiology, November 1, 2007; 58(5): 579 - 585. [Abstract] [PDF] |
||||
![]() |
C. J. Boos, D. A. Lane, M. Karpha, D. G. Beevers, R. Haynes, and G. Y. H. Lip Circulating Endothelial Cells, Arterial Stiffness, and Cardiovascular Risk Stratification in Hypertension Chest, November 1, 2007; 132(5): 1540 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, B. Pannier, C. Vlachopoulos, I. Wilkinson, H. Struijker-Boudier, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur. Heart J., November 1, 2006; 27(21): 2588 - 2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Brillante, M. T Johnstone, and L. G Howes Effects of Intravenous PD 123319 on Haemodynamic and Arterial Stiffness Indices in Healthy Volunteers Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 102 - 106. [Abstract] [PDF] |
||||
![]() |
J. J. Oliver and D. J. Webb Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 554 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Hayward, M. Kraidly, C. M. Webb, and P. Collins Assessment of endothelial function using peripheral waveform analysis: A clinical application J. Am. Coll. Cardiol., August 7, 2002; 40(3): 521 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.S. Mackenzie, I.B. Wilkinson, and J.R. Cockcroft Assessment of arterial stiffness in clinical practice QJM, February 1, 2002; 95(2): 67 - 74. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |